Biofrontera soars on revenue outlook

Biofrontera

08/04/2022 13:29

** Biofrontera Inc  BFRI.O  climbs 31% premarket to $5.31
before paring gains to trade at $4.72 
    ** Co set to open at its highest since January, if gains
hold
    ** Biopharmaceutical co said it expects total revenues in
2022 to increase by at least 30% from last year
    ** Co posted $24.1 mln in revenue for 2021, up 28% from
previous year
    ** BFRI raised gross proceeds of $18 mln from an initial
public offering and $15 mln from a subsequent private placement
after it filed to go public in July last year
    

 (Reporting by Mehnaz Yasmin in Bengaluru)
 ((Mehnaz.Yasmin@thomsonreuters.com))